Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells

Journal of Molecular Endocrinology

Volumn 51, Issue 1, 2013, Pages 131-141

  Tsui, Ke Hung ^a   Chung, Li Chuan ^b   Wang, Shyi Wu ^b   Feng, Tsui Hsia ^b   Chang, Phei Lang ^a   Juang, Horng Heng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Gene regulation; Metabolism; Prostate; Signal transduction

Indexed keywords

ACONITATE HYDRATASE; DNA FRAGMENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; MIMOSINE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL HYPOXIA; CELL STRAIN LNCAP; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; IRON CHELATION; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TRANSLATION INITIATION;

GENE REGULATION; METABOLISM; PROSTATE; SIGNAL TRANSDUCTION;

ACONITATE HYDRATASE; CARCINOMA; CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MITOCHONDRIA; PROSTATIC NEOPLASMS;

EID: 84879921155     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0090     Document Type: Article

References (45)

1. Alaoui-Jamali MA, Bismar TA, Gupta A, Szarek WA, Su J, Song W, Xu Y, Xu B, Liu G, Vlahakis JZ et al. 2009 A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Research 69 8017-8024. (doi:10.1158/0008-5472.CAN-09-0419)
2. Baron A, Migita T, Tang D & Loda M 2004 Fatty acid synthase: a metabolic oncogene in prostate cancer? Journal of Cellular Biochemistry 91 47-53. (doi:10.1002/jcb.10708)
3. Bertilsson H, Tessem M-B, Flatberg A, Viset T, Gribbestad I, Angelsen A & Halgunset J 2012 Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples. Clinical Cancer Research 18 3261-3269. (doi:10.1158/1078-0432.CCR-11-2929)
4. Bourdeau-Heller J & Oberley TD 2007 Prostate carcinoma cells selected by long-term exposure to reduced oxygen tension show remarkable biochemical plasticity via modulation of superoxide, HIF-1a levels, and energy metabolism. Journal of Cellular Physiology 212 744-752. (doi:10.1002/jcp.21069)
5. Chang SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL & Loscalzo J 2009 MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metabolism 10 273-284. (doi:10.1016/j.cmet.2009.08.015)
6. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL & Juang HH 2011 Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Molecular Nutrition & Food Research 55 1666-1676. (doi:10.1002/mnfr. 201100328)
7. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL & Juang HH 2012 L-mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. American Journal of Physiology. Cell Physiology 302 C676-C685. (doi:10.1152/ajpcell.00180.2011)
8. Costello LC & Franklin RB 1994 The bioenergetic theory of prostate malignancy. Prostate 25 162-166. (doi:10.1002/pros.2990250308)
9. Costello LC & Franklin RB 2005 Why do tumour cells glycolyse?: From glycolysis through citrate to lipogenesis Molecular and Cellular Biochemistry 280 1-8. (doi:10.1007/s11010-005-8841-8)
10. Costello LC & Franklin RB 2012 The genetic/metabolic transformation concept of carcinogenesis. Cancer Metastasis Reviews 31 123-130. (doi:10.1007/s10555-011-9334-8)
11. DeBerardinis RJ 2008 Is cancer a disease of abnormal cellular metabolism? New angles on an old idea Genetics in Medicine 10 767-777. (doi:10.1097/GIM.0b013e31818b0d9b)
12. Feng TH, Tsui KH & Juang HH 2005 Cholesterol modulation of the expression of mitochondrial aconitase in human prostatic carcinoma cells. Chinese Journal of Physiology 48 93-100.
13. Flavin R, Zadra G & Loda M 2011 Metabolic alterations and targeted therapies in prostate cancer. Journal of Pathology 223 283-294. (doi:10.1002/path.2809)
14. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, Hirota S, Hosobe S, Tsukada T, Miura K et al. 2008 Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Research 68 1003-1011. (doi:10.1158/0008-5472.CAN-07-2489)
15. Gozzelino R, Jeney V & Soares MP 2010 Mechanisms of cell protection by heme oxygenase-1. Annual Review of Pharmacology and Toxicology 50 323-354. (doi:10.1146/annurev.pharmtox.010909.105600)
16. Higgins LH, Withers HG, Garbens A, Love HD, Magnoni L, Hayward SW & Moyes CD 2009 Hypoxia and the metabolic phenotype of prostate cancer cells. Biochimica et Biophysica Acta 1787 1433-1443. (doi:10.1016/j.bbabio.2009.06.003)
17. Hochachka PW, Rupert JL, Goldenberg L, Gleave M & Kozlowski P 2002 Going malignant: the hypoxia-cancer connection in the prostate. BioEssays 24 749-757. (doi:10.1002/bies.10131)
18. Hu H, Deng C, Yang T, Chen Y, Nice EC, Huang C & Wei Y 2011 Proteomics revisits the cancer metabolome. Expert Review of Proteomics 84 505-553. (doi:10.1586/epr.11.31)
19. Ji C, Marnett LJ & Pietenpol JA 1997 Cell cycle re-entry following chemically-induced cell cycle synchronization leads to elevated p53 and p21 protein levels. Oncogene 15 2749-2753. (doi:10.1038/sj.onc. 1201441)
20. Juang HH 2004a Modulation of mitochondrial aconitase on the bioenergy of human prostate carcinoma cells. Molecular Genetics and Metabolism 81 244-252. (doi:10.1016/j.ymgme.2003.12.009)
21. Juang HH 2004b Modulation of iron on mitochondrial aconitase expression in human prostatic carcinoma cells. Molecular and Cellular Biochemistry 265 185-194. (doi:10.1023/B:MCBI.0000044395. 59739.1f)
22. 0-monosphosphate mediate prolactin regulation of mitochondrial aconitase in human prostate carcinoma cells. Molecular and Cellular Endocrinology 219 141-149. (doi:10.1016/ j.mce.2004.01.001)
23. Juang HH, Hsieh ML & Tsui KH 2004 Testosterone modulates mitochondrial aconitase in the full-length human androgen receptor-transfected PC-3 prostatic carcinoma cells. Journal of Molecular Endocrinology 33 121-132. (doi:10.1677/jme.0.0330121)
24. Kroemer G & Pouyssegur J 2008 Tumor cells metabolism: cancer's Achilles' heel. Cancer Cell 13 472-482. (doi:10.1016/j.ccr.2008.05.005)
25. Kung AL, Zabludoff SD, France DS, Freedman SJ, Tanner EA, Vieira A, Cornell-Kennon S, Lee J, Wang B, Wang J et al. 2004 Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6 33-43. (doi:10.1016/j.ccr.2004.06.009)
26. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL & Dang CV 2010 Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. PNAS 107 2037-2042. (doi:10.1073/pnas.0914433107)
27. Li Y, Su J, DingZhang X, Zhang J, Yoshimoto M, Liu S, Bijian K, Gupta A, Squire JA, Alaoui-Jamali MA et al. 2011 PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome. Journal of Pathology 224 90-100. (doi:10.1002/path.2855)
28. Liu Y 2006 Fatty acid oxidation is dominant bioenergetic pathway in prostate cancer. Prostate Cancer and Prostatic Diseases 3 230-234. (doi:10.1038/sj.pcan.4500879)
29. Marignol L, Coffey M, Lawler M & Hollywood D 2008 Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treatment Reviews 34 313-327. (doi:10.1016/j.ctrv.2008.01.006)
30. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E et al. 2009 Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. Journal of the National Cancer Institute 101 519-532. (doi:10.1093/jnci/djp030)
31. Mycielska ME, Broke-Smith TP, Palmer CP, Beckerman R, Nastos T, Erguler K & Djamgoz MB 2006 Citrate enhances in vitro metastatic behaviours of PC-3M human prostate cancer cells: status of endogenous citrate and dependence on aconitase and fatty acid synthase. International Journal of Biochemistry & Cell Biology 38 1766-1777. (doi:10.1016/j.biocel.2006.04.008)
32. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Flowler AA III & Kukreja RC 2005 HIF-1 activation attenuates postichemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. American Journal of Physiology. Heart and Circulatory Physiology 289 H542-H548. (doi:10.1152/ajpheart. 00089.2005)
33. Schneider BD & Leibold EA 2003 Effects of iron regulatory protein regulation on iron homeostasis during hypoxia. Blood 102 3404-3411. (doi:10.1182/blood-2003-02-0433)
34. Schodel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ & Mole DR 2011 High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117 e207-e217. (doi:10.1182/blood-2010-10-314427)
35. Semenza GL 2007 Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochemical Journal 405 1-9. (doi:10.1042/BJ20070389)
36. Semenza GL 2012 Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends in Pharmacological Sciences 33 207-214. (doi:10.1016/j.tips.2012.01.005)
37. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P & Giallongo A 1996 Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry 271 32529-32537. (doi:10.1074/jbc.271.51.32529)
38. Tsui KH, Chang PL & Juang HH 2006 Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells. International Journal of Cancer 118 609-615. (doi:10.1002/ijc.21411)
39. Tsui KH, Feng TH, Lin YF, Chang PL & Juang HH 2011 p53 Downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. Prostate 71 62-70. (doi:10.1002/pros.21222)
40. Tsui KH, Chang YL, Feng TH, Chung LC, Lee TY, Chang PL & Juang HH 2012 Growth differentiation factor-15 upregulates interleukin-6 to promoter tumorigenesis of prostate carcinoma PC-3 cells. Journal of Molecular Endocrinology 49 153-163. (doi:10.1530/JME-11-0149)
41. Wang GL, Jiang BH, Rue EA & Semenza GL 1995 Hypoxia inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. PNAS 92 5510-5514. (doi:10.1073/pnas.92.12.5510)
42. Warburg O 1956 On respiratory impairment in cancer cells. Science 124 269-270.
43. Yamada Y, Nakamura K, Aoki S, Tobiume M, Zennami K, Kato Y, Nishikawa G, Yoshizawa T, Itoh Y, Nakaoka A et al. 2011 Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer. Oncology Reports 25 937-944. (doi:10.3892/or.2011.1154)
44. Yeung SJ, Pan J & Lee MH 2008 Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cellular and Molecular Life Sciences 65 3981-3999. (doi:10.1007/s00018-008-8224-x)
45. Zhang P, Tchou-Wong KM & Costa M 2007 Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Research 67 9125-9133. (doi:10.1158/0008-5472.CAN-07-1525)